We'll call the meeting to order.
We are continuing our study of the Canada-European Union free trade agreement, I guess technically the comprehensive economic and trade agreement.
I'm would just remind the committee that we are the only committee sitting this week. I don't know what they do in other committees, but we've got places to go, people to see, things to do. I appreciate all of your being here this morning and taking part in this important study.
We do have with us Spirits Canada and Rx&D, Canada's Research-Based Pharmaceutical Companies.
We'll hear from Spirits Canada first, Jan Westcott, president and chief executive officer.
We'll open the floor to your presentation first, and then we'll get to Mr. Russell.